X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare FDC LTD. with Torrent Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

FDC LTD. vs TORRENT PHARMA - Comparison Results

TORRENT PHARMA 
   Change

Torrent Pharmaceuticals Ltd. is the flagship company of the Torrent Group set up in 1959. Based in Ahmedabad, it was promoted by Mr U.N. Mehta initially as Trinity Laboratories Ltd. and was later renamed to its current name. The company derives its r... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    FDC LTD. TORRENT PHARMA FDC LTD./
TORRENT PHARMA
 
P/E (TTM) x 22.2 44.8 49.6% View Chart
P/BV x 5.0 6.3 78.9% View Chart
Dividend Yield % 0.9 0.8 117.0%  

Financials

 FDC LTD.   TORRENT PHARMA
EQUITY SHARE DATA
    FDC LTD.
Mar-14
TORRENT PHARMA
Mar-18
FDC LTD./
TORRENT PHARMA
5-Yr Chart
Click to enlarge
High Rs1441,550 9.3%   
Low Rs791,144 6.9%   
Sales per share (Unadj.) Rs47.6354.7 13.4%  
Earnings per share (Unadj.) Rs7.640.1 19.0%  
Cash flow per share (Unadj.) Rs9.064.2 14.0%  
Dividends per share (Unadj.) Rs2.2514.00 16.1%  
Dividend yield (eoy) %2.01.0 194.6%  
Book value per share (Unadj.) Rs47.5273.1 17.4%  
Shares outstanding (eoy) m177.83169.22 105.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x2.33.8 61.6%   
Avg P/E ratio x14.633.6 43.5%  
P/CF ratio (eoy) x12.321.0 58.9%  
Price / Book Value ratio x2.34.9 47.5%  
Dividend payout %29.634.9 84.6%   
Avg Mkt Cap Rs m19,784227,897 8.7%   
No. of employees `000NA14.7 0.0%   
Total wages/salary Rs m1,22111,353 10.8%   
Avg. sales/employee Rs ThNM4,083.0-  
Avg. wages/employee Rs ThNM772.3-  
Avg. net profit/employee Rs ThNM461.3-  
INCOME DATA
Net Sales Rs m8,45960,021 14.1%  
Other income Rs m3942,988 13.2%   
Total revenues Rs m8,85263,009 14.0%   
Gross profit Rs m2,07013,493 15.3%  
Depreciation Rs m2494,086 6.1%   
Interest Rs m313,085 1.0%   
Profit before tax Rs m2,1849,310 23.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m-2250-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6062,529 23.9%   
Profit after tax Rs m1,3536,781 20.0%  
Gross profit margin %24.522.5 108.9%  
Effective tax rate %27.727.2 102.1%   
Net profit margin %16.011.3 141.6%  
BALANCE SHEET DATA
Current assets Rs m4,35552,623 8.3%   
Current liabilities Rs m1,79252,022 3.4%   
Net working cap to sales %30.31.0 3,024.0%  
Current ratio x2.41.0 240.3%  
Inventory Days Days44120 37.2%  
Debtors Days Days2576 32.4%  
Net fixed assets Rs m3,02585,016 3.6%   
Share capital Rs m179846 21.1%   
"Free" reserves Rs m8,24345,376 18.2%   
Net worth Rs m8,45346,222 18.3%   
Long term debt Rs m1141,115 0.0%   
Total assets Rs m10,557142,432 7.4%  
Interest coverage x71.44.0 1,777.4%   
Debt to equity ratio x00.9 0.1%  
Sales to assets ratio x0.80.4 190.1%   
Return on assets %13.16.9 189.3%  
Return on equity %16.014.7 109.1%  
Return on capital %23.514.2 165.6%  
Exports to sales %13.30-   
Imports to sales %3.30-   
Exports (fob) Rs m1,126NA-   
Imports (cif) Rs m283NA-   
Fx inflow Rs m1,14614,580 7.9%   
Fx outflow Rs m3553,600 9.9%   
Net fx Rs m79110,980 7.2%   
CASH FLOW
From Operations Rs m1,4858,942 16.6%  
From Investments Rs m-620-47,070 1.3%  
From Financial Activity Rs m-75334,174 -2.2%  
Net Cashflow Rs m113-3,655 -3.1%  

Share Holding

Indian Promoters % 68.9 71.5 96.4%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 4.7 7.0 67.0%  
FIIs % 7.5 12.6 59.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 19.0 8.8 215.9%  
Shareholders   23,730 26,511 89.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare FDC LTD. With:   MERCK LTD  CIPLA  ASTRAZENECA PHARMA  VENUS REMEDIES  STERLING BIOTECH  

Compare FDC LTD. With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Slumps Over 275 Points; Realty and Banking Stocks Witness Selling(Closing)

After trading on a volatile note throughout the day, share markets in India witnessed selling pressure during the closing hours and ended the day in red.

Related Views on News

TORRENT PHARMA Announces Quarterly Results (1QFY19); Net Profit Down 13.3% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, TORRENT PHARMA has posted a net profit of Rs 2 bn (down 13.3% YoY). Sales on the other hand came in at Rs 19 bn (up 36.2% YoY). Read on for a complete analysis of TORRENT PHARMA's quarterly results.

FDC LTD. Announces Quarterly Results (1QFY19); Net Profit Up 74.5% (Quarterly Result Update)

Aug 6, 2018 | Updated on Aug 6, 2018

For the quarter ended June 2018, FDC LTD. has posted a net profit of Rs 511 m (up 74.5% YoY). Sales on the other hand came in at Rs 3 bn (up 16.7% YoY). Read on for a complete analysis of FDC LTD.'s quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Dr Reddy's: Milestone Payment Drives Sales (Quarterly Results Update - Detailed)

Feb 9, 2018

US business was hit by pricing pressure although there was growth sequentially led by new product launches.

Lupin: US market Declines Due to Higher Base Effect of FY17 (Quarterly Results Update - Detailed)

Feb 9, 2018

Price erosion in generic US drugs continues but seems to be bottoming out.

More Views on News

Most Popular

Is It the Right Time to Buy Pharma Stocks Now?(The 5 Minute Wrapup)

Sep 12, 2018

Is the pharma sector poised for a comeback? Is the worst over? I believe so.

Want Bigger Returns Than You Thought Possible? This is Where You Should Look(Profit Hunter)

Sep 12, 2018

Richa has discovered the single most profitable opportunity in the market - read on to discover more...

Investors Are Redeeming From Equity Mutual Funds Now. Should You?(Outside View)

Sep 12, 2018

PersonalFN elucidates if you should redeem from equity mutual fund now, and the approach to follow before you decide to sell mutual funds.

Are You Blindly Investing In Equities? Read This...(Outside View)

Sep 11, 2018

PersonalFN explains how blindly investing in equities can prove hazardous to your wealth and health.

Outperformance of Strong Established Brands in the Indian Stock market(Chart Of The Day)

Sep 14, 2018

Strong Well established Indian Brands have comfortably outperformed the index in the decade post the global financial crisis.

More

Small Investments
BIG Returns

Zero To Millions Guide 2018
Get our special report, Zero To Millions
(2018 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

FDC LTD. SHARE PRICE


Sep 21, 2018 (Close)

TRACK FDC LTD.

  • Track your investment in FDC LTD. with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

FDC LTD. - FRESENIUS KABI ONCO. COMPARISON

COMPARE FDC LTD. WITH

MARKET STATS